As previously communicated, the generic form of Lipitor became available on November 30, 2011. Through a limited-time program with Lipitor?s manufacturer, IBC commercial members could obtain brand Lipitor from November 30, 2011, to May 31, 2012, at the same level of cost-sharing they pay for generic drugs (i.e., lowest level of cost-sharing).

The program is ending

Starting June 1, 2012, members who have been prescribed brand Lipitor should make the switch to its generic form, atorvastatin. On this date, brand Lipitor will become a non-formulary brand medication and will only be available to members at the highest non-formulary level of cost-sharing. Members who are currently taking brand Lipitor will receive a letter to remind them of the program?s end date. As of June 1, 2012, members should request that their pharmacy substitute brand Lipitor with the generic equivalent, atorvastatin, if their pharmacy does not automatically do so. This will ensure that members continue to pay the lowest formulary level of cost-sharing. Going forward, the pharmacy will dispense atorvastatin unless you have indicated ?dispense as written? on the prescription.